REPLIGEN CORPORATION - COMMON STOCK

Repligen Appoints Martin D. Madaus to Board of Directors

09 فبراير 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Repligen to Report Fourth Quarter and Full Year 2022 Financial Results

08 فبراير 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference

03 يناير 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at Upcoming Investor Conferences

08 نوفمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance

01 نوفمبر 2022 07:30:01 بحسب Nasdaq GlobeNewswire

Repligen Extends and Expands Long-Term Supply Agreement with Purolite for Affinity Ligands

01 نوفمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Repligen to Report Third Quarter 2022 Financial Results

12 أكتوبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement

19 سبتمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Repligen To Host Investor Day 2022

24 أغسطس 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Repligen Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Financial Guidance

02 أغسطس 2022 07:30:01 بحسب Nasdaq GlobeNewswire

Repligen to Report Second Quarter 2022 Financial Results

19 يوليو 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors

26 مايو 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at Upcoming Investor Conferences

25 مايو 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Repligen Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance

27 أبريل 2022 07:30:01 بحسب Nasdaq GlobeNewswire

Repligen to Report First Quarter 2022 Financial Results

13 أبريل 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum

18 مارس 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Repligen Reports Fourth Quarter and Full Year 2021 Financial Results

17 فبراير 2022 07:30:01 بحسب Nasdaq GlobeNewswire

Repligen Launches AAV Affinity Resins for Gene Therapy Purification

15 فبراير 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at 11th Annual SVB Leerink Healthcare Conference

11 فبراير 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Repligen to Report Fourth Quarter and Full Year 2021 Financial Results

03 فبراير 2022 09:30:09 بحسب Nasdaq GlobeNewswire